Heidelberg Pharma Forecast, price target & analysts
Heidelberg Pharma Target price 2026 - Analyst rating & recommendation
Heidelberg Pharma Classifications & Recommendation
Heidelberg Pharma Price Target
| Target Price | €5.61 |
| Price | €2.54 |
| Potential |
120.87%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Heidelberg Pharma 2027 .
The average Heidelberg Pharma target price is €5.61.
This is
120.87%
register free of charge
€5.78
127.36%
register free of charge
€5.56
118.70%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Heidelberg Pharma to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Heidelberg Pharma stock has an average upside potential 2027 of
120.87%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Nov '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 1.46 | 10.20 |
| 78.69% | 598.63% | |
| EBITDA Margin | -2,946.58% | -130.50% |
| 778.33% | 95.57% | |
| Net Margin | -2,895.89% | -135.66% |
| 923.57% | 95.32% |
3 Analysts have issued a sales forecast Heidelberg Pharma 2026 . The average Heidelberg Pharma sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Heidelberg Pharma EBITDA forecast 2026. The average Heidelberg Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Heidelberg Pharma Analysts have issued a net profit forecast 2026. The average Heidelberg Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Nov '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | -0.91 | -0.30 |
| 116.67% | 67.03% | |
| P/E | negative | |
| EV/Sales | 14.26 |
4 Analysts have issued a Heidelberg Pharma forecast for earnings per share. The average Heidelberg Pharma EPS is
This results in the following potential growth metrics and future valuations:
Heidelberg Pharma...
Current Heidelberg Pharma Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Dec 08 2025 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Jun 23 2026 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Dec 08 2025 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Sep 11 2025 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Jul 18 2025 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Mar 31 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
